Table 3.
DIEYAG Instructions.
| Utilization: | When ingrowth is clinically significant (central, progressing, and/or causing reduced visual acuity or increased visual symptoms), and when patient prefers laser treatment over more invasive surgical options |
| Settings: |
|
| Assessment: | Before DIEYAG: Define extent of the ingrowth observed on biomicroscopy; approximate borders are also seen as hyperreflective areas on corneal cross section with Pentacam |
| Successful treatment: Bubbles at interface between the flap and stromal bed appear when laser energy is applied directly to areas of ingrowth | |
| Follow up: Halting of progression and gradual dissolution of ingrowth are observed on biomicroscopy and Pentacam corneal cross section |